Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Qianju Enterprise Management Partnership (Limited Partnership) is a Chinese investment and equity management vehicle primarily associated with the leadership of Zai Lab, a prominent global biopharmaceutical company. Established in 2014 and headquartered in Shanghai, the partnership serves as a strategic holding entity for the founders and executive management to manage their ownership interests in Zai Lab. It does not engage in direct scientific research, drug development, or manufacturing; rather, its operations are focused on investment management and corporate governance within the healthcare sector. The partnership's significance lies in its role as a major shareholder in Zai Lab, reflecting the long-term commitment of the company's core leadership to its growth and success in the innovative medicine market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qianju Enterprise Management Partnership.